BIO P174 Dansyl Arm Treatment Study #19 – 2 Groups


BIO P174 Dansyl Arm Treatment Study #19 – 2 Groups
Posted  June 3, 2024

START DATE06/10/2024
QUALIFICATIONSFemales Ages: 35-65
TIME REQUIREMENT18 visits
COMPENSATION$195

Prescreening is required in our Bio Department. Come in anytime to prescreen. 

Study hours: 8:30am – 4:10pm

Study dates and Groups 

Group 1

VISIT 1:    MON. 6/10 – 20 MINS.
VISIT 2:    TUES. 6/25 – 15 MINS.
VISIT 3:    WED. 6/26 – 15 MINS.
VISIT 4 – 18:        6/27 to 7/19 – 15 MINS

 

Group – 2

VISIT 1:    TUES 6/11 – 20 MINS.
VISIT 2:    TUES. 6/25 – 15 MINS.
VISIT 3:    WED. 6/26 – 15 MINS.
VISIT 4 – 18:       6/27 to 7/19 – 15 MINS

*No visits on 7/4/24 and 7/5/24 due to Independence Day, Eurofins | CRL will be closed. Subjects can not miss the visits on Wednesday 7/3/24 or Monday 7/8/24, or they will be discontinued from the study.

 

Conflicting Studies: Arm Studies/Body Wash studies/12 Hour Spray Deodorant.

 

Inclusion Criteria 

  • Subject is female between 35 and 65 years of age.
  • Subject agrees not to introduce any new cosmetic or toiletry products during the study.
  • Subject agrees to refrain from swimming, sauna, hammam (Turkish bath) for the duration of the study.
  • Subject agrees to refrain from rigorous exercises and swimming for the 24 hours between patch application and patch removal.
  • Subject is willing to avoid extended periods of sun exposure for the duration of the study (including artificial tanning);
  • Subject agrees to discontinue use of any other soaps, lotions, creams, and sunscreens on the forearm, with the exception of the soap provided for use during the study.
  • Subject is willing to continue with normal washing (with the provided soap) and refrain from the use of washcloths, loofahs, or coarse sponges on test sites.

Exclusion Criteria 

  • Subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;
  • Subject is currently using any systemic or topical corticosteroids, anti-inflammatory drugs, antihistamines, or retinoids or any medication that, in the opinion of the Principal Investigator, may influence the outcome of the study.
  • Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs.
  • Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would preclude application of the test material and/or could influence the outcome of the study.
  • Subject has participated in a study involving the arm as a test site within two weeks of study initiation.
  • Subject exhibits irritation, excessive hair, tattoos, sunburn, rashes, scratches, burn marks, scarring, etc. on the test sites, which might interfere with evaluation of test results.
  • Subject reports a history of allergies to tape adhesives.
  • Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study.
  • Subject has a history of skin cancer or is currently undergoing treatment for active cancer of any kind.
  • Subject has diabetes

 

Call our Recruiting Department for more information and to sign up for this study. 

 




Sign up today!